Recent Finacing
Recent Raise
Aclaris Therapeutics develops A-101, a topical therapeutic for removing seborrheic keratosis and verrucoid lesions, conducting Phase 2b trials toward an FDA new drug application.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
